Latest News about bladder cancer
Recent news which mentions bladder cancer
From Benzinga
ImmunityBio Expects To Submit US Application For VesAnktiva In Bladder Cancer This Month
April 04, 2022
Tickers
IBRX
From Benzinga
From Benzinga
Astellas Pharma - Seagen's Enfortumab Shows 36% Pathologic Complete Response In Bladder Cancer Patients
February 15, 2022
From Benzinga
From Benzinga
Sesen Bio To Conduct Additional Trial For Potential Resubmission Of Vicineum In Bladder Cancer
December 09, 2021
Tickers
SESN
From Benzinga
Sesen Bio Shares Gain On FDA Type A Meeting On Issues From Vicineum Response Letter
October 20, 2021
Tickers
SESN
From Benzinga
Astellas Pharma's Bladder Cancer Treatment Scores Approval In Japan
September 27, 2021
From Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
September 21, 2021
From Benzinga
Janssen Shares Erdafitinib Combo Therapy Data In Bladder Cancer
September 17, 2021
Tickers
JNJ
From Benzinga
FDA Extends Full Approval For Merck's Keytruda In 1st-Line Bladder Cancer
September 01, 2021
Tickers
MRK
From Benzinga
After FDA Rejection Troubled Biotech Pulls Europe Application For Bladder Cancer Drug
August 26, 2021
Tickers
SESN
From Benzinga